Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
World J Surg. 2023 May;47(5):1201-1208. doi: 10.1007/s00268-023-06932-7. Epub 2023 Feb 17.
The aim of this study was to evaluate a new surgical technique by the European Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) Study Group.
This study included 391 patients (47 [(12%]) male and 344 [(88%)] female) who had undergone endoscopic thyroid or parathyroid surgery via the vestibular approach between February 2016 and May 2022 at nine centers. The data were analyzed with regard to complications, surgery time and specimen retrieval.
Overall, 376 (96.2%) TOETVA and 15 (3.8%) transoral endoscopic parathyroidectomy vestibular approach interventions were performed with an average surgery time of 145 (± 61.2) minutes and 509 nerves at risk. The specimens were retrieved via a transoral vestibular and retroauricular approach in 66 (16.9%) patients and via a transaxillary approach in 8 (2%). Benign histology including Grave's disease was identified in 272 (69.6%) patients, 1 (0.3%) presented noninvasive follicular thyroid neoplasms with papillary-like nuclear features, and 103 (26.3%) showed differentiated thyroid carcinoma. Solitary parathyroid adenoma were removed in 15 (3.8%) patients. Conversion to open surgery was necessary in 13 (3.3%) and revision had to be performed in 2 (0.5%) patients. Transient recurrent laryngeal nerve palsy (RLNP) was present in 18 (4.6%) and permanent RLNP in 2 (0.5%) patients. Fifteen (3.8%) patients experienced transient hypoparathyroidism after thyroidectomy. No case of permanent hypoparathyroidism was observed. Postoperative surgical site infection occurred in 1 (0.3%) patient. Despite a higher rate of sensory and motor disorders and skin discoloration at discharge, permanent disorders were present in only 3 (0.8%) and 16 (4.1%) patients, respectively.
Our results show that transoral endoscopic surgery, performed by experienced endocrine surgeons, is a safe alternative to conventional thyroid surgery.
本研究旨在由欧洲经口内镜甲状腺手术前庭入路(TOETVA)研究组评估一种新的手术技术。
本研究纳入了 2016 年 2 月至 2022 年 5 月间在 9 个中心行内镜甲状腺或甲状旁腺手术的 391 例患者(47 例男性[12%]和 344 例女性[88%])。对并发症、手术时间和标本取出情况进行分析。
总体而言,376 例(96.2%)TOETVA 和 15 例(3.8%)经口内镜甲状旁腺切除术前庭入路手术,平均手术时间为 145(±61.2)分钟,有 509 条风险神经。66 例(16.9%)患者通过经口前庭和耳后入路、8 例(2%)患者通过经腋入路取出标本。272 例(69.6%)患者的组织学为良性,包括格雷夫斯病,1 例(0.3%)为非侵袭性滤泡性甲状腺肿瘤伴乳头状核特征,103 例(26.3%)为分化型甲状腺癌。15 例(3.8%)患者为单发甲状旁腺腺瘤。13 例(3.3%)患者转为开放性手术,2 例(0.5%)患者需行修正手术。18 例(4.6%)患者出现暂时性喉返神经麻痹(RLNP),2 例(0.5%)患者出现永久性 RLNP。15 例(3.8%)甲状腺切除术后出现短暂性甲状旁腺功能减退。无永久性甲状旁腺功能减退的病例。1 例(0.3%)患者发生术后手术部位感染。尽管出院时感觉和运动障碍以及皮肤变色的发生率较高,但永久性障碍仅分别见于 3 例(0.8%)和 16 例(4.1%)患者。
我们的研究结果表明,经口内镜手术由经验丰富的内分泌外科医生完成,是传统甲状腺手术的一种安全替代方法。